C
Cleerly
A digital healthcare company transforming the way clinicians approach the treatment of heart disease
About Cleerly
Cleerly Health is a digital healthcare startup that is revolutionizing the approach to treating heart disease. The company operates in the healthcare market, specifically focusing on cardiovascular care. It uses artificial intelligence (AI) to analyze coronary computed tomography angiography (CCTA) imaging, which is a type of heart scan. This allows clinicians to identify and define atherosclerosis, a condition where plaque builds up in the heart's arteries, at an earlier stage.
Cleerly Health's business model is centered around its AI-based digital care platform. This platform transforms complex imaging data into actionable insights, enabling clinicians to provide personalized treatment plans for their patients. The company's primary clients are healthcare providers, who use the platform to improve their clinical and financial outcomes.
The company's innovative approach allows for a more precise evaluation of heart disease, going beyond traditional measures by analyzing, characterizing, and quantifying types of plaque. This enables healthcare providers to more accurately determine a patient's risk of heart attack and develop a treatment plan to improve heart health.
Cleerly Health generates revenue by offering its digital cardiovascular care management program to healthcare providers. This program includes digital and print tools that transform complex imaging data into actionable clinical insights.
In summary, Cleerly Health is a digital healthcare startup that uses AI to help healthcare providers more accurately diagnose and treat heart disease, leading to improved patient outcomes and financial benefits for the providers.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Denver, United States
- Employees
- 354
- Open positions
- 29
- Dealroom signal
- 93.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Medical Imaging, Core AI, Spinout, Rumoured $1B, Biotech and Pharma, AI for medical imaging, Techbio
- Technology
- Artificial Intelligence
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Dec 2024 | $106M | $1.1B | Battery Ventures · Insight Partners | ↗ |
| SERIES COther financing | Jul 2022 | $223M | $892M | Mirae Asset Capital · LRVHealth · Presight Capital · New Leaf Ventures | ↗ |
Growth signals
Latest recorded traffic for Cleerly is 27K monthly website visits, down 48.1% over the last three months. Cleerly's team grew 88.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
ImpactAssets
Esplanade Ventures- CCCavendish Impact Capital
LRVHealth
DigiTx Partners
Cigna Ventures
New Leaf Venture Partners
American College of Cardiology
Vensana Capital
Series B and later12 investors entered at this stage
General Catalyst
T. Rowe Price
Fidelity Investments
Mirae Asset Capital
Presight Capital
New Leaf Ventures
Peter Thiel
Novartis
Breyer Capital
Piper Sandler
Insight Partners
Battery Ventures
Other known investors2 additional known investors
New York Presbyterian Hospital
Weill Cornell Medicine
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cleerly on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cleerly’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







